CORMORANT ASSET MANAGEMENT, LP – Turning Point Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$0
portfolio value
Turning Point Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -2.48M shares | -186.93M | $0 | 0 |
| Q2 2022 | share | Decrease | -32.86% | -1.21M shares | 87.59M | $75.25 | 2.48M |
| Q1 2022 | share | Increase | +22.31% | 675K shares | -44.94M | $26.85 | 3.7M |
| Q4 2021 | share | Increase | +6.43% | 182.70K shares | -44.52M | $48.63 | 3.02M |
| Q3 2021 | share | Decrease | -6.41% | -194.74K shares | -48.13M | $66.43 | 2.84M |
| Q2 2021 | share | Increase | +10.44% | 287.04K shares | -23.17M | $78.02 | 3.03M |
| Q1 2021 | share | Increase | +14.95% | 357.70K shares | -31.37M | $94.59 | 2.75M |
| Q4 2020 | share | Decrease | -2.05% | -50K shares | 78.14M | $121.85 | 2.39M |
| Q3 2020 | share | Decrease | -10.78% | -295K shares | 36.55M | $87.36 | 2.44M |
| Q2 2020 | share | Decrease | -10.45% | -319.5K shares | 40.28M | $64.59 | 2.73M |
| Q1 2020 | share | Decrease | -10.01% | -339.85K shares | -75.06M | $44.66 | 3.05M |
| Q4 2019 | share | Decrease | -4.09% | -144.71K shares | 78.42M | $62.29 | 3.39M |
| Q3 2019 | share | Increase | +13.42% | 419K shares | 6.07M | $37.6 | 3.54M |
| Q2 2019 | share | Increase | 0.00% | 3.12M shares | 127.08M | $40.7 | 3.12M |